Skip to content

Clinical trials

Lung Diseases trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Greece Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20082
20101
20121
20132
20172
20181
20194
20211
20221
20233
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting6
Terminated3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Bayer2
Novartis Pharmaceuticals2
United Therapeutics2
Aeris Therapeutics1
Cardeas Pharma1
Celgene1
Consorcio Centro de Investigación Biomédica en Red (CIBER)1
Eli Lilly and Company1
Elpen Pharmaceutical Co. Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases23
Respiratory Tract Diseases8
Pulmonary Disease, Chronic Obstructive6
Carcinoma, Non-Small-Cell Lung4
Respiratory Tract Infections4
Connective Tissue Diseases3
Lung Neoplasms3
Asthma2
Bronchitis, Chronic2
COVID-192

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.